Keywords: Liver, Liver, Liver fibrosis, biopsyChronic liver diseases can lead to variable amounts of liver fibrosis, which impacts patient management and outcomes. Percutaneous liver biopsy is the clinical reference standard for assessment of liver fibrosis. However, biopsy is subject to sampling errors and poor patient acceptance. The aim of this study is to develop machine learning models to stratify the severity of biopsy-derived liver fibrosis using MR radiomic data and clinical data. Using clinical, routinely collected MRI and clinical data, our machine learning was able to stratify the severity of liver fibrosis with an AUROC of 0.71, demonstrating the feasibility of the machine learning approaches.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords